Discover the potential and pitfalls of psychopharmacogenomic (PGx) testing in mental health treatment. Dr. Sulman Aziz Mirza, the triple board-certified psychiatrist, breaks down how genetic testing aims to personalize psychiatric medication selection and potentially reduce side effects.
Learn about:
- How PGx testing works and its goals in psychiatry
- The controversy surrounding genetic testing for medication response
- When genetic insights can be beneficial in guiding treatment
- Potential risks and downsides of relying on PGx results
-The future of personalized medicine in mental health
This video explores the complex world of pharmacogenomics, discussing both its promise and limitations. Understand why major organizations like the FDA and AACAP urge caution and discover the specific genes considered clinically actionable in psychiatry.
Is DNA-based medication selection the key to more effective mental health treatment, or is it just one piece of a larger puzzle?
Join the discussion and share your thoughts in the comments!
#GeneticTesting #PsychiatricMedication #PersonalizedMedicine #MentalHealthTreatment #Pharmacogenomics #PGxTesting #MedicationResponse
Chapters
0:00 Intro
1:18 What is pharmacogenomic testing?
3:13 Concerns about PGx testing
5:28 Potential real-life uses
7:25 Potential risks of testing
10:13 So, what's the verdict?
Hosted on Acast. See acast.com/privacy for more information.
